Singapore: Southeast Asia’s first heart transplant patient and one of the world’s longest surviving cases has died, his family said today, more than 31 years after his operation. Singaporean Seah Chiang Nee, a former newspaper editor, died aged 76 in a local hospital on Saturday, his wife Patricia Wong told AFP. He was hospitalised in July.
Seah underwent heart transplant surgery on October 12, 1985 in Sydney, when doctors removed his organ in a five-and-a-half hour operation and replaced it with that of a 17-year-old boy who had just died. “Based on his record he should be one of the longest-surviving in the world,” said Kenneth Ng, a cardiologist at the Mount Elizabeth Novena Hospital in Singapore.
“The median survival rate for heart transplant is only 10 years… so it is definitely on the high end.” The world’s longest surviving heart transplant patient was a Briton named John McCafferty, who died at age 73 last year, 33 years after the transplant, according to British media reports. In an interview with AFP in 2005, 20 years after the operation, Seah said he would have been content to live for
four or five years after the transplant.
He said he had never imagined he would be able to welcome the new millennium. “Twenty years is a long, long time and I’m already very grateful,” he said then.
- COVID case rates hit new high for England, study finds - April 7, 2022
- Govt’s focus on affordable healthcare ensured significant savings for poor, middle class: PM Modi - April 7, 2022
- SRL Diagnostics and Skye Air Mobility collaborate to transport pathology samples using drone logistics - April 6, 2022
- Healthineers sets up new production line of CT scanners in Bengaluru under PLI scheme - April 6, 2022
- Lupin inks licensing pact with Alvion to market drugs in Southeast Asia - April 6, 2022
- Yoga Mahotsav: Ayush Ministry to organise event to demonstrate common yoga on World Health Day - April 6, 2022
- LordsMed forays into the medtech space with launch of health ATMs ‘Lords Sehat’ - April 5, 2022
- ‘Friendly viruses’ can be the next big thing in the history of medical research and more - April 5, 2022
- No setback to Bharat Biotech even as WHO suspends Covaxin UN supply: Sources - April 4, 2022
- Govt panel recommends Serum’s Covovax dose for kids aged 12 and above - April 4, 2022
